Receptor Activator of Nuclear Factor Kappa B (RANK) Expression in Primary Breast Cancer Correlates with Recurrence Free Survival and Development of Bone Metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)
- Citation:
- Breast Cancer Res Treat vol 165 (1) 129-38
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 6
- Parents:
- 672
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821 , U10 CA180821
- Corr. Author:
- Authors:
- Neelima Vidula Christina Yau Jiali Li Laura J. Esserman Hope S. Rugo
- Networks:
- Study
- CALGB-150007
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- N/A
- Keywords:
- Receptor Activator of Nuclear Factor Kappa B (RANK), RANK ligand (RANKL), Osteoprotegerin (OPG), Bone metastases, Breast cancer, Recurrence Free Survival